In this study, we aimed to assess SLC3A2 gene copy number (CN) and mRNA expression alongside protein expression in large and well-characterised annotated cohorts of BC to determine its clinicopathological and prognostic value with emphasis on the different molecular classes. Here, SLC3A2 is linked to breast cancer.